The spectrum of peripheral T-cell lymphomas

Area of Science:

• Hematology
• Oncology
• Pathobiology

Background:

• Peripheral T-cell lymphomas (PTCLs) are a diverse group of aggressive non-Hodgkin lymphomas.
• Understanding their pathobiology and prognosis is crucial for improved patient outcomes.
• The World Health Organization classification of lymphoid neoplasms has recently been updated.

Purpose of the Study:

• To summarize recent progress in understanding PTCL pathobiology and prognosis.
• To highlight changes in the updated World Health Organization classification of lymphoid neoplasms.
• To discuss advancements in identifying prognostic markers and therapeutic targets for PTCLs.

Main Methods:

• Review of recent scientific literature and collaborative project findings.
• Analysis of clinico-pathologic and geographic data from the International Peripheral T-Cell Lymphoma Project.
• Exploration of molecular profiling studies to identify PTCL subgroups.

Main Results:

• PTCL, not otherwise specified, is biologically heterogeneous.
• Angioimmunoblastic T-cell lymphoma shares features with follicular T-helper cells.
• Anaplastic large cell lymphoma (ALCL) comprises ALK-positive (better prognosis) and ALK-negative subtypes, which are distinct entities with different prognoses.

Conclusions:

• Advances in understanding PTCL subtypes are refining diagnoses.
• New potential prognostic markers and therapeutic targets are being identified.
• Molecular distinctions confirm separate entities within PTCLs, aiding in targeted therapies.